Increased awareness, early diagnosis and the introduction of novel, targeted therapies, have led to significantly improved outcomes for breast cancer patients. However, there are many challenges that remain, particularly in improving the outcome for patients with triple negative and metastatic disease, overcoming therapeutic resistance, and improving quality of life for patients during and after cancer care.
This meeting is a follow up to the BACR's previous successful breast cancer meeting 2019 held at the same venue which was highly rated by the participants and aims to bring together both clinicians and scientists with an interest in breast cancer research.
This meeting will cover the most recent developments in breast cancer research with world-leading speakers providing their latest perspective to each topic. The programme contains insights into newly emerging breast cancer treatments, including advances being made in the area of DNA damage inhibitors and treatments designed to overcome chemo-resistance.
To complement the increasing use of targeted and immunotherapies in breast cancer, there will be focussed on genetic, epigenetic, molecular, immunological and microenvironmental drivers of metastasis.
Additional sessions will be dedicated to discussing critical gaps and identifying priorities in breast cancer treatment, including male breast cancer. There will also be a resource-based session aimed at guiding researchers through the process of obtaining high quality tissue, model systems and/or data to optimise their research output.
In addition, there will be several oral presentations selected from the submitted abstracts, offering junior investigators and students the opportunity to present their work to an expert audience. An evening programme is focussed on future career options of early career researchers, including discussions on becoming a research fellow, moving to industry and transitioning to becoming a university lecturer.
If you have any special dietary requirements - please let us know.
Your email address will be retained in our electronic registration database and used for correspondence from the BACR.
List of Participants
If you attend, we will include your name and country in the printed programme book unless you request to be removed.
Please click below if you agree for your email address to be included in the printed List of Participants that is given to all attendees and exhibitors.
Please note: you have selected for your email address NOT to appear in the List of Participants.
You can click above to change this.
BACR is a registered charity in England and Wales (289297)
c/o Leeds Institute of Medical Research at St James’s, Cancer Genetics Building,
St James's University Hospital, Beckett Street, Leeds LS9 7TF